NCT04238195
A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects
Phase: Phase 1
Role: Collaborator
Start: Jan 19, 2020
Completion: Feb 26, 2020